J45 J45.0 J45.1 J45.8 J45.9
Conditions
Interventions
Group 1: In Arm 1, the included participants were provided with the SaniQ application to record their vital signs. The measurement requirements were as follows: During the first 4 weeks, vital signs w
from week 5 onward, vital signs were to be measured at least 1 time per day thereafter.
Group 2: In Arm 2, included participants were provided with a handwritten health diary. The measurement requirem
Sponsors
Qurasoft GmbHUniversitätsstraße 356070 Koblenz
Eligibility
Sex/Gender
All
Age
16 Years to 75 Years
Inclusion criteria
Inclusion criteria: Bronchial asthma unspecified, mixed forms of bronchial asthma, nonallergic bronchial asthma and predominantly allergic asthma, nonsmoker or max. 10 pack years
Exclusion criteria
Exclusion criteria: Patients must not have had an exacerbation in the 6 weeks prior to the first study visit, no COPD patients, must not have participated in a medical study for 12 weeks prior to the study visit
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At baseline, perform AQLQ, ACT, adherence ( requirement: 4 weeks 2x/day, then 1x/day); after three months, perform AQLQ, ACT, adherence (review requirement). | — |
Countries
Germany
Contacts
Public ContactErwin Junker
Qurasoft GmbHUniversitätsstraße 356070 Koblenz
Outcome results
None listed